Article · 9 Nov 2026
Conference abstract
Synthesis and in vitro anticancer studies of novel coumarin substituted thiazolidin-4-ones
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Thiazolidin-4-ones and coumarins are important pharmacodynamic heterocyclic scaffolds which have been reported to possess potent anti-inflammatory and anticancer properties. The combination of two pharmacophores on the same molecule is a well-established approach for the designing of potent molecules and further substitution on these scaffolds may further enhance their activity. Therefore a series of coumarin substituted thiazolidin-4-ones were synthesized and evaluated for their anticancer activity. Initially 3-acetylamiocoumarin was synthesized by cyclocondensation of salicyladehyde with N-acetylglycine. Acid hydrolysis of 3-acetylaminocoumarin afforded 3-aminocoumarin. Finally one pot reaction of 3-aminocoumarin and thioglycolic acid with different aldehydes in dry toluene yielded the corresponding coumarin substituted thiazolidin-4-ones. Structures of final compounds were confirmed by IR, NMR and Mass techniques. Among the fifteen coumarin substituted thiazolidin-4-ones screened for their in vitro cytotoxic effect on T47D and HeLa human cancer cell lines, compounds, 2-(3-fluorophenyl)-3-(2-oxo-2H-chromen-3-yl)thiazolidin-4-one (NKT-7), 2-(2-fluorophenyl)-3-(2-oxo- 2H-chromen-3-yl)thiazolidin-4-one (NKT-8) and 2-(5-methylthiophen-2-yl)-3-(2-oxo-2H-chromen-3-yl) thiazolidin-4-one (NKT-14) exhibited maximum cytotoxicity with IC50 values below 2.5?g/ml. Other moderately active compounds were NKT- 4, NKT-5, NKT-6, NKT-7, NKT-13 and NKT-15 showing IC50 value between 3.45-14.67 ?g/ml. The most active compounds NKT-7, NKT-8 and NKT-14 exhibited apoptosis mediated cell death as confirmed by Hoechst staining studies. Thiophen substituted thiazolidin-4-ones and fluoro/bromo/nitro phenyl substituted thiazolidin-4-ones were found to more cytotoxic than other thiazolidinones. These novel leads molecules can be further modified and screened to improve their anticancer activity.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Pharmacology.
Article · 23 Feb 2026
A Thorough Overview of Polycystic Ovary Syndrome (PCOS) in Female Rats
Article · 19 Dec 2025
Theoretical Pharmacology: Understanding Drug Action Through Models and Principles
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Alex Joseph”
- BylineArticles whose byline prints “Neeraj Kumar Soni”
- BylineArticles whose byline prints “Jesil Mathew A”
- BylineArticles whose byline prints “Angel Treasa Alex”
